Data Supplement from SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies

Abstract

Supplementary Methods, Table and Figure Legends. Supplementary Table S1. Serum level of IgG in multiple myeloma patient samples.